DIZAL JIANGSU PHARMACEUTIC

Stable Trading: Dizal Jiangsu Pharmaceutical Holds Steady at CNY 62.06 Despite Market Volatility

Stable trading for Shanghai’s Dizal Jiangsu Pharmaceutical: flat 0% change, CNY 62.06, strong 200‑day SMA, solid capitalisation—analyzing long‑term upside.

DIZAL JIANGSU PHARMACEUTIC
China
AI generated

Jake Connors

23/10/2026, 08:40

3 minutes to read

Steady Momentum: Dizal Jiangsu Pharma Maintains Growth Amid China’s Shifting Drug Market

Explore how Dizal Jiangsu Pharmaceutical’s steady trading, cost‑cutting, and upcoming biologics pipeline position it ahead in China’s tightening pharma market.

DIZAL JIANGSU PHARMACEUTIC
China
AI generated

Samantha Roth

22/10/2026, 12:20

4 minutes to read

Stable Growth & Strong Liquidity: Dizal Jiangsu Pharma’s 2026 Snapshot

Stable Dizal Jiangsu Pharmaceutical shares at CNY 62.64, steady growth, solid fundamentals, and a strong 200‑day SMA for long‑term investors.

DIZAL JIANGSU PHARMACEUTIC
China
AI generated

Samantha Roth

22/10/2026, 04:49

2 minutes to read